QLP2117

DRUG2 trials

Sponsors

Qilu Pharmaceutical Co., Ltd.

Conditions

Advanced Solid TumorAdvanced Solid Tumors

Phase 1

A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors

RecruitingNCT05830045

Qilu Pharmaceutical Co., Ltd.Advanced Solid Tumors

Start: 2023-05-19End: 2025-12-31Target: 180Updated: 2024-06-27

A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients

RecruitingNCT06911827

Qilu Pharmaceutical Co., Ltd.Advanced Solid Tumor

Start: 2025-05-09End: 2028-12-01Target: 90Updated: 2026-02-25